Abstract
Objectives
To characterize biomarkers that underlie osteosarcoma (OS) metastasis based on an ego-network.
Results
From the microarray data, we obtained 13,326 genes. By combining PPI data and microarray data, 10,520 shared genes were found and constructed into ego-networks. 17 significant ego-networks were identified with p < 0.05. In the pathway enrichment analysis, seven ego-networks were identified with the most significant pathway.
Conclusions
These significant ego-modules were potential biomarkers that reveal the potential mechanisms in OS metastasis, which may contribute to understanding cancer prognoses and providing new perspectives in the treatment of cancer.
Similar content being viewed by others
References
Ahn T, Lee E, Huh N, Park T (2014) Personalized identification of altered pathways in cancer using accumulated normal tissue data. Bioinformatics 30:i422–i429
Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D, Levine AJ (1999) Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 96:6745–6750
Artero-Castro A, Castellvi J, Garcia A, Hernandez J, Ramon y Cajal S, Lleonart ME (2011) Expression of the ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors. Hum Pathol 42:194–203
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 57:289–300
Bertaux K, Broux O, Chauveau C, Jeanfils J, Devedjian JC (2005) Identification of CBFA1-regulated genes on SaOs-2 cells. J Bone Miner Metab 23:114–122
Borgatti SP, Mehra A, Brass DJ, Labianca G (2009) Network analysis in the social sciences. Science 323:892–895
Buddingh EP, Kuijjer ML, Duim RA, Burger H, Agelopoulos K, Myklebost O, Serra M, Mertens F, Hogendoorn PC, Lankester AC, Cleton-Jansen AM (2011) Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents. Clin Cancer Res 17:2110–2119
Dey P, Jonsson P, Hartman J, Williams C, Strom A, Gustafsson JA (2012) Estrogen receptors beta1 and beta2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. Mol Endocrinol 26:1991–2003
Diboun I, Wernisch L, Orengo CA, Koltzenburg M (2006) Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genom 7:252
Edmonds BT, Wyckoff J, Yeung YG, Wang Y, Stanley ER, Jones J, Segall J, Condeelis J (1996) Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma. J Cell Sci 109:2705–2714
Feldman L, Rouleau C (2002) Troponin I inhibits capillary endothelial cell proliferation by interaction with the cell’s bFGF receptor. Microvasc Res 63:41–49
Goldstein SD, Trucco M, Guzman WB, Hayashi M, Loeb DM (2016) A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model. Oncotarget 7:21114–21123
Grade M, Hummon AB, Camps J, Emons G, Spitzner M, Gaedcke J, Hoermann P, Ebner R, Becker H, Difilippantonio MJ, Ghadimi BM, Beissbarth T, Caplen NJ, Ried T (2011) A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets. Int J Cancer 128:1069–1079
Imamura K, Imamachi N, Akizuki G, Kumakura M, Kawaguchi A, Nagata K, Kato A, Kawaguchi Y, Sato H, Yoneda M, Kai C, Yada T, Suzuki Y, Yamada T, Ozawa T, Kaneki K, Inoue T, Kobayashi M, Kodama T, Wada Y, Sekimizu K, Akimitsu N (2014) Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol Cell 53:393–406
Isakoff MS, Bielack SS, Meltzer P, Gorlick R (2015) Osteosarcoma: current treatment and a collaborative pathway to success. J Clin Oncol 33:3029–3035
Jia P, Kao CF, Kuo PH, Zhao Z (2011) A comprehensive network and pathway analysis of candidate genes in major depressive disorder. BMC Syst Biol 5(Suppl 3):S12
Ma X, Gao L, Karamanlidis G, Gao P, Lee CF, Garcia-Menendez L, Tian R, Tan K (2015) Revealing pathway dynamics in heart diseases by analyzing multiple differential networks. PLoS Comput Biol 11:e1004332
Meissner M, Dechat T, Gerner C, Grimm R, Foisner R, Sauermann G (2000) Differential nuclear localization and nuclear matrix association of the splicing factors PSF and PTB. J Cell Biochem 76:559–566
Meyers PA (2009) Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma. Expert Rev Anticancer Ther 9:1035–1049
Perucho L, Artero-Castro A, Guerrero S, Ramon y Cajal S, LLeonart ME, Wang ZQ (2014) RPLP1, a crucial ribosomal protein for embryonic development of the nervous system. PLoS ONE 9:e99956
Rienzo M, Schiano C, Casamassimi A, Grimaldi V, Infante T, Napoli C (2013) Identification of valid reference housekeeping genes for gene expression analysis in tumor neovascularization studies. Clin Transl Oncol 15:211–218
Roos A, Satterfield L, Zhao S, Fuja D, Shuck R, Hicks MJ, Donehower LA, Yustein JT (2015) Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis. Br J Cancer 113:1289–1297
Sakellariou A, Spyrou G (2015) mAPKL: R/Bioconductor package for detecting gene exemplars and revealing their characteristics. BMC Bioinform 16:291
Selga E, Oleaga C, Ramirez S, de Almagro MC, Noe V, Ciudad CJ (2009) Networking of differentially expressed genes in human cancer cells resistant to methotrexate. Genome Med 1(9):83
Stratford JK, Bentrem DJ, Anderson JM, Fan C, Volmar KA, Marron JS, Routh ED, Caskey LS, Samuel JC, Der CJ, Thorne LB, Calvo BF, Kim HJ, Talamonti MS, Iacobuzio-Donahue CA, Hollingsworth MA, Perou CM, Yeh JJ (2010) A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. PLoS Med 7:e1000307
Sun R, Shen J, Gao Y, Zhou Y, Yu Z, Hornicek F, Kan Q, Duan Z (2016) Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential. Oncotarget 7:38333–38346
Tang N, Song WX, Luo J, Haydon RC, He TC (2008) Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res 466:2114–2130
Tretter F, Albus M (2008) Systems biology and psychiatry - modeling molecular and cellular networks of mental disorders. Pharmacopsychiatry 41(Suppl 1):S2–S18
Venet D, Dumont JE, Detours V (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol 7:e1002240
Wang D, He F, Zhang L, Zhang F, Wang Q, Qian X, Pan X, Meng J, Peng C, Shen A, Chen J (2011a) The role of p27(Kip1) phosphorylation at serine 10 in the migration of malignant glioma cells in vitro. Neoplasma 58:65–73
Wang M, Hu Y, Amatangelo MD, Stearns ME (2011b) Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer. Mol Cancer Res 9:36–50
Yang R, Bai Y, Qin Z, Yu T (2014) EgoNet: identification of human disease ego-network modules. BMC Genom 15:314
Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW (1997) Gene expression profiles in normal and cancer cells. Science 276:1268–1272
Zhu X, Wang F, Zhao Y, Yang P, Chen J, Sun H, Liu L, Li W, Pan L, Guo Y, Kou Z, Zhang Y, Zhou C, He J, Zhang X, Li J, Han W, Li J, Liu G, Gao S, Yang Z (2014) A gain-of-function mutation in Tnni2 impeded bone development through increasing Hif3a expression in DA2B mice. PLoS Genet 10:e1004589
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Z., Song, Y. Characterizing biomarkers in osteosarcoma metastasis based on an ego-network. Biotechnol Lett 39, 841–848 (2017). https://doi.org/10.1007/s10529-017-2305-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-017-2305-6